Vascular Biology and Metabolism (VAM)

Overview

The Vascular Biology and Metabolism (VAM) area was created to enable a comprehensive, cooperative and multidisciplinary approach to research, development and transference of solutions for a group of diseases that are the leading cause of morbidity and mortality in the world: cardio- and neurovascular diseases, diabetes-metabolic syndrome and kidney failure.

This area also includes a group focused on Ophtalmology research and the Medical Molecular Imaging multidisciplinary group.

Publications

230

total

1,274.219

impact factor

5.542

average impact factor

Director: Joan Castell Conesa

team

zoom

download

During 2017, we had made several advances such as:
1) The set-up of a new protocol to assess myocardial viability on diabetic population through PET/CT, thanks to set-up a clinical trial aimed to phenotyping insulin resistance on diabetic population
2) The set-up of a new protocol to assess infectious endocarditis through PET/CT, which currently has been added on the European and American guidelines for the management of infective endocarditis
3) The set-up of a new facility for treatments with radioactive isotopes in cancer patients, which allows us to develop a new research
4) The development of a new methodology with 1H-NMR to perform multi-omics analyses of different populations of peripheral blood cells, plasma and serum based on metabolomics, allowing us the develop of biomarkers.
Finally, we have been founded by Horizon2020 to set a new line of research aimed to develop multi-diagnostic agents for visualizing stem cells in vivo and methodologies to evaluate and predict muscle regeneration.

Vascular Biology and Metabolism (VAM)

Overview

Publications

Director: Joan Castell Conesa

Research Areas